Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TAK
Recent news which mentions TAK
< Previous
1
2
3
4
5
6
Next >
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
Tickers
CRNX
NXGN
OBIO
RSI
Tags
Small Cap
Overbought stocks
RSI
From
Benzinga
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
September 18, 2023
Tickers
ASIA
MRK
NVAX
PFE
Tags
Benzinga
General
FDA
From
Benzinga
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
Tickers
IMGN
TAK
Tags
Health Care
Expert Ideas
Briefs
From
Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
September 08, 2023
Tickers
TAK
Tags
TAK
Trading Ideas
Benzinga
From
Benzinga
ImmunoGen Inks Pact With Takeda To Develop ELAHERE Ovarian Cancer Drug In Japan
August 28, 2023
Tickers
IMGN
TAK
Tags
Contracts
Health Care
Markets
From
Benzinga
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
August 24, 2023
Tickers
TAK
VTRS
Tags
TAK
Market News
Recent Press Releases
From
Motley Fool
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now
August 23, 2023
Tickers
T
TAK
Tags
Recent Press Releases
Market News
TAK
From
Motley Fool
How Is The Market Feeling About Takeda Pharmaceutical?
August 17, 2023
Tickers
TAK
Tags
Trading Ideas
TAK
Short Sellers
From
Benzinga
Why Are Poseida Therapeutics Shares Moving Higher Today?
August 07, 2023
Tickers
PSTX
TAK
Tags
ALMPF
Health Care
why it's moving
From
Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
August 01, 2023
Tickers
TAK
Tags
Short Sellers
Benzinga
Trading Ideas
From
Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
July 14, 2023
Tickers
TAK
Tags
TAK
Trading Ideas
Benzinga
From
Benzinga
Disney Considers Different Strategies For Star India, Broadcom Wins Conditional European Approval For VMware Deal, Google Deprioritizes Gen Z Chatbot App: Today's Top Stories
July 12, 2023
Tickers
ARKK
ATVI
AVGO
BRK-A
Tags
FFIE
IBM
HYMTF
From
Benzinga
Takeda Withdraws FDA Application For Dengue Vaccine Candidate On Data Disagreement
July 12, 2023
Tickers
SNY
TAK
Tags
Health Care
Market News
Biotech
From
Benzinga
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
June 21, 2023
Tickers
TAK
TEVA
Tags
Biotech
Market News
Health Care
From
Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
Tickers
ARGX
AZN
HALO
TAK
Tags
Analyst Ratings
Market News
Biotech
From
Benzinga
3 AI Stocks That Could Skyrocket Your Wealth
June 20, 2023
Tickers
AMAT
BMY
INTC
NVDA
Tags
SDGR
BMY
NYSE:BMY,NASDAQ:INTC,NASDAQ:AMAT,NASDAQ:SDGR,NYSE:TAK,NASDAQ:NVDA
From
InvestorPlace
Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma Setting
June 13, 2023
Tickers
SGEN
TAK
Tags
Benzinga
General
TAK
From
Benzinga
3 Stocks That Could Skyrocket by This Time Next Summer
June 08, 2023
Tickers
CELH
MNSO
MNST
MORF
Tags
PEP
Stocks to Buy
TAK
From
InvestorPlace
Why Shares of Innate Pharma Jumped Thursday
June 08, 2023
Tickers
IPHA
SNY
TAK
Tags
IPHA
TAK
SNY
From
Motley Fool
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
May 19, 2023
Tickers
ABBV
JNJ
TAK
Tags
Health Care
JNJ
Benzinga
From
Benzinga
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
May 11, 2023
Tickers
TAK
TBPH
TKPHF
Tags
Benzinga
Movers
General
From
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Tickers
RAIN
RCEL
REAX
RGTI
Tags
SIEN
VERU
TK
From
Benzinga
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
May 11, 2023
Tickers
TAK
TKPHF
Tags
why it's moving
Guidance
Health Care
From
Benzinga
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
April 25, 2023
Tickers
CBD
KHRNF
MRMD
PEP
Tags
MRMD
Penny Stocks
Equilibria
From
Benzinga
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
April 25, 2023
Tickers
AMGN
ARWR
GSK
TAK
Tags
GSK
TAK
Recent Press Releases
From
Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
April 25, 2023
Tickers
ABBV
ABT
BMY
GILD
Tags
BMY
MRK
ABT
From
Motley Fool
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
Tickers
GSK
MRK
SNY
TAK
Tags
Government
TAK
MRK
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 11, 2023
Tickers
AGFY
AMC
BNRG
CLEU
Tags
Market News
FNCH
ZFOX
From
InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
April 04, 2023
Tickers
AVAV
AXP
DHR
ETSY
Tags
PT Changes
Benzinga
News
From
Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
Tickers
BMY
TAK
TKPHF
Tags
Benzinga
General
Briefs
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.